| Date | Title | Description |
| 24.11.2023 | Discover the latest updates on our company and investments in life science | NEWS. On November 9, 2023, Sciety invited its investor network to an exclusive event on the theme of future scenarios and opportunities within life science. The evening featured a panel discussion on data-driven precision medicine with Tomm... |
| 10.11.2023 | Investor event with a focus on opportunities within life science | NEWS. On November 9, 2023, Sciety invited its investor network to an exclusive event on the theme of future scenarios and opportunities within life science. The evening featured a panel discussion on data-driven precision medicine with Tomm... |
| 09.11.2023 | Sciety’s portfolio company Neogap raises SEK 83 million | PRESS RELEASE. Sciety och Sciety Venture Partners have invested SEK 54 million in Neogap Therapeutics (Neogap), a Swedish clinical-stage biotech company that develops personalised immunotherapy for cancer treatment with the help of two emer... |
| 02.10.2023 | Sciety’s portfolio company PharmNovo reports positive headline results in clinical phase I study | PRESS RELEASE. Sciety’s portfolio company PharmNovo, a Swedish pharmaceutical company based in Lund, reports positive results in its clinical phase I study of a drug candidate for nerve pain – an area currently lacking safe and effective tr... |
| 28.08.2023 | Sciety expands the team with three Communication Specialists | NEWS. In response to the increasing demand for Sciety’s services, we are happy to announce the addition of three new Communication Specialists to our team. At Sciety, we believe in the importance of clear investor communication. Communicati... |
| 26.06.2023 | Sciety’s spring summary 2023 | Spring 2023 was an interesting time for Sciety. Our goal is to make scientific breakthroughs in medicine and technology available to people all over the world. This is why we strive to help innovative companies within life science and digit... |
| 21.06.2023 | Sciety strengthens board with Tommi Unkuri – partner at Summa Equity | |
| 29.05.2023 | Sciety and Sciety Venture Partners invest EUR 1.5 million | Sciety, a leading Nordic investment company focusing on innovative life science and health tech companies, along with Sciety Venture Partners, invest EUR 1.5 million in Encare. In the funding round, targeting primarily existing shareholders... |
| 11.05.2023 | Sciety and Sciety Venture Partners invest EUR 5.3 million in Capitainer | Sciety and Sciety Venture Partners recently completed an investment of EUR 5.3 million in Capitainer, a Swedish medtech company that has developed a unique platform for self-sampling of blood, facilitating remote healthcare solutions and pe... |
| 12.01.2023 | Sciety invests in a company developing targeted radioimmunotherapy for incurable cancer | Sciety and the network Sciety Venture Partners have invested SEK 68 million in the Swedish radioimmunotherapy company Akiram Therapeutics. The investment company Linc AB participated in the share issue with SEK 20 million. Akiram is develop... |
| 19.09.2022 | Sciety invests in leading health tech company in surgery | PRESS RELEASE. The Sciety syndicate has invested SEK 26 million in Swedish health tech company Encare, whose SaaS solution enables health care providers to improve surgery outcomes. The new capital will finance Encare’s global expansion and... |
| 03.06.2022 | Sciety and Karolinska Development invest SEK 67 million in PharmNovo | PRESS RELEASE. The Swedish pharmaceutical company PharmNovo, which is developing a new type of drug for nerve pain, has raised SEK 67 million in a new share issue led by Sciety. Karolinska Development AB participated in the share issue with... |
| 31.05.2022 | Sciety invests SEK 34 million in Capitainer – an innovator of home-sampling solutions | PRESS RELEASE. Capitainer, a Swedish MedTech company supplying reliable solutions for self-sampling of blood and plasma, has raised a further SEK 34 million with Sciety and its investment syndicate in a new share issue. The company will use... |
| 12.05.2022 | Safer surgery saves lives – Swedish health-tech player takes the lead for improved quality of care | NEW COMPANY AT SCIETY. Long waiting time for surgery, deficiencies in patient safety, and high costs for care related to surgery. Healthcare faces significant challenges in Sweden and internationally while the demands for quality-improving ... |
| 22.12.2021 | Sciety invests in cutting-edge biotech company NEOGAP Therapeutics | PRESS RELEASE. Sciety recently made an investment of over SEK 58 million in the cell therapy company NEOGAP Therapeutics, which is developing personalised immunotherapy for the treatment of cancer. The new capital will be used for a clinica... |
| 25.10.2021 | Sciety invests in Synartro that develops novel therapy for osteoarthritis | PRESS RELEASE. The Swedish biotechnology company Synartro, which is developing a novel, improved treatment for knee osteoarthritis, has successfully raised SEK 34 million with Sciety and its investment syndicate. The new capital will be use... |
| 30.06.2021 | The Sciety syndicate and Segulah Medical Acceleration invest MSEK 106 in SAGA Diagnostics | PRESS RELEASE. The Swedish diagnostics company SAGA Diagnostics, which develops ultrasensitive liquid biopsy tests for early detection of cancer relapse and personalized cancer treatment, recently completed a share issue of SEK 106 million ... |
| 05.05.2021 | Company that develops novel osteoarthritis treatment raises capital with Sciety | NEW COMPANY AT SCIETY. Osteoarthritis affects more than 320 million people globally and is a leading source of chronic pain and disability in Europe and the US. Only half of the patients receive adequate pain relief. Sciety is now financing... |
| 09.02.2021 | 49 MSEK to EMPE Diagnostics with focus on rapid tuberculosis diagnostics | EMPE Diagnostics, which has developed a rapid test for the diagnosis and resistance determination of tuberculosis, the world’s deadliest infectious disease, has recently completed a share issue of SEK 23.5 million with Sciety. The company h... |
| 18.01.2021 | The Sciety syndicate invests MSEK 31 in Capitainer | PRESS RELEASE. Capitainer, a Swedish Medtech company that supplies intelligent solutions for self-sampling of blood and plasma, recently completed a share issue of SEK 31 million with Sciety and its investment syndicate. The investors demon... |
| 24.11.2020 | Company that develops innovative blood sampling raises capital with Sciety | NEW COMPANY AT SCIETY. Most blood sampling is still performed by qualified healthcare personnel at care facilities, but new technology that enables simple and reliable home sampling is now changing the landscape. Sciety finances a Swedish c... |
| 11.09.2020 | Cartana is acquired by 10x Genomics for 425 MSEK | PRESS RELEASE. The American biotechnology company 10x Genomics acquires the Swedish company Cartana, which was financed by the Sciety investment syndicate two years ago. |
| 18.05.2020 | Interview with Mats Nilsson, serial entrepreneur at SciLifeLab | |
| 04.05.2020 | The Sciety syndicate invests in Synartro that develops a novel drug for osteoarthritis | The Sciety syndicate invests in Synartro, which uses existing drugs with proven efficacy to develop an improved drug treatment of knee osteoarthritis. The new capital will be used to complete the pre-clinical development. The company plans ... |
| 21.04.2020 | Interview with Pavan Asalapuram, co-founder of EMPE Diagnostics | Sciety talks with Pavan Asalapuram, co-founder of EMPE Diagnostics, a company that develops rapid diagnostic solutions for infectious diseases, with a special focus on tuberculosis––a major public health problem in big parts of the world. E... |
| 31.03.2020 | The Sciety syndicate invests MSEK 9.1 in a cardiovascular diagnostic company | The Sciety investment syndicate recently made an investment of 9.1 million SEK in the company Cavis Technologies, which has developed Wirecath®––a patent-pending product for the diagnosis of coronary heart diseases. The new capital will be ... |
| 24.03.2020 | New diagnostic technology can reduce mortality in one of the world’s most common infectious diseases | Today, Sciety wants to pay attention to World TB Day, which aims to highlight the extensive health, social and economic consequences of tuberculosis. Tuberculosis is a contagious infectious disease that primarily affects the lungs but also ... |
| 06.02.2020 | New technology can contribute to safer diagnoses of diseases of the coronary heart | |
| 23.01.2020 | Sciety invests in cancer diagnostics of the future with Industrifonden | Sciety invests SEK 35 million in the company Elypta, which is developing a new method for early cancer diagnosis. The Sciety network together with the Swedish venture capital fund Industrifonden, Chalmers Ventures and several of the company... |
| 03.12.2019 | Sciety network invests in Predicare, the company that aims to streamline emergency care around the world | The Sciety investment syndicate recently completed an investment of MSEK 9 in Predicare, a company that has developed RETTS––a system used by the majority of Sweden’s emergency units. The new capital will be used to expand in selected Europ... |
| 26.09.2019 | Predicare is growing––new customers in Norway | During September, Predicare finalised an agreement with two new clients in Norway––a hospital and an ambulance services company. Predicare continues to grow rapidly in Norway and their RETTS© system is used by 31 out of 49 hospitals with em... |
| 29.08.2019 | EMPE Diagnostics raises MSEK 9 for launch in India | This week, EMPE Diagnostics completed a new share issue of a total of SEK 9.2 million with Sciety. The company has developed a quick test for tuberculosis and the new capital will support the establishment of operations in India where tuber... |
| 12.06.2019 | The Sciety syndicate invests MSEK 15 in cutting-edge company specializing in DNA sequencing | This week, Single Technologies completed a new share issue of 15 million SEK with Sciety. The company has developed a DNA sequencing solution, which makes it possible to analyse larger amounts of data faster and cheaper than before. The new... |
| 14.05.2019 | Athera Biotechnologies raises MSEK 55 with the help of Sciety | This week, pharmaceutical company Athera Biotechnologies, completed a new share issue of SEK 55 million in which Industrifonden, Östersjöstiftelsen and the Sciety investment syndicate participated. The new capital is to be used for a clinic... |
| 02.04.2019 | Sciety raises new capital for a medtech company to continue their expansion in Europe | Medtech company Likvor raises new capital for its continued expansion in Europe. They currently have about ten hospitals as clients. The company’s system is used to diagnose the dementia-like disorder, NPH. |
| 26.03.2019 | Sciety raises new capital for pharma company within fat-related diseases | Lipigon Pharmaceuticals has raised SEK 8 million in a new share issue to finance the continued pre-clinical development of pharmaceuticals within fat-related diseases, so-called lipid-related disorders. Lipid imbalance cause common diseases... |
| 11.02.2019 | Sciety arranges two private placements | Sciety is currently capitalizing a Phase II pharmaceutical company and a DNA sequencing tech company––both via private placements. The companies operate in high growth markets and raise new capital to achieve product development goals that ... |
| 26.11.2018 | New venture at Sciety – develops drugs for diseases caused by high levels of blood lipids | Lipid imbalances does not only cause common diseases such as diabetes and cardiovascular diseases but also various rare diseases. The pharma company Lipigon is specialised in diseases caused by lipid imbalances, with an initial focus on rar... |
| 09.10.2018 | Sciety raises new capital to medtech company in neurology and cancer | CARTANA raised almost 10 million SEK in a share issue that was fully subscribed at the end of September. The company has developed reagents for analysing tissue samples in drug development processes and is based at Karolinska in Stockholm. ... |
| 19.09.2018 | New venture at Sciety – wants to help researchers in the search for new treatments | Cartana is based at Karolinska Institute in Stockholm and has developed a new technology for researchers to analyse tissue samples in drug development processes. The company is ready to launch at the market for brain research and will launc... |
| 29.08.2018 | 5 common questions about investing in unlisted companies | If you’re used to buying shares on the stock market, it doesn’t have to be a big leap to invest in unlisted companies as well. At Sciety, we frequently receive questions from people who are considering making their first investment in an un... |
| 22.08.2018 | Opportunity to join Cartana – their technology revolutionizes the brain research | Neurological disorders have been pinpointed by WHO as one of the greatest threats to public health. As an example, nearly 10 million people develop dementia each year and the number of people living with dementia is expected to triple from ... |
| 18.06.2018 | Sciety becomes a member in SwedenBIO | Sciety becomes a member in the trade association SwedenBIO that works for a strong life science sector in Sweden. The members include micro companies to big pharma but also companies that provide services in business development, IP, financ... |
| 12.06.2018 | Sciety raises MSEK 10 to diagnostics company fighting the tuberculosis epidemic | The new issue of shares in EMPE Diagnostics was fully subscribed already two weeks before the subscription period expired. EMPE Diagnostics develops a rapid test for diagnosis of tuberculosis. In total, 10 million SEK was invested and the f... |
| 22.05.2018 | An entrepreneurial and investor perspective on the action plan for Swedish life science | Last week, the trade associations LIF, Swedish Medtech and SwedenBIO presented an action plan to strengthen the competitiveness of Swedish life science. As Sciety meets many companies that develop the healthcare sector, we find it is very i... |
| 11.04.2018 | Sciety raises 10 MSEK via its financing platform for companies in the life science sector | Sciety closes a financing round of 10 million SEK and welcomes thirty new shareholders with backgrounds in the finance and healthcare sectors. The largest investor is the investment company Linc. |
| 14.03.2018 | Attana is the second company to be listed after financing via Sciety | One week ago, the medical technology company Attana that previously raised funding via Sciety listed its shares on the NGM stock exchange. The company has developed technology to improve efficiency in the development of new drugs and is the... |
| 06.04.2017 | Major investment interest in award-wining 1928 Diagnostics | Ett trettiotal affärsänglar går in med 20 miljoner kronor i diagnostikbolaget som med sin innovativa mjukvara ska bekämpa det globala hotet från antibiotikaresistens. Investeringarna sker via Sciety som är specialiserat på tillväxtbolag ino... |
| 21.12.2016 | Sciety raises MSEK 6 for the tech company Inhalation Sciences | The investments come partly from a business angel network and a venture capital company that already owns shares in the company and partly from new financiers, each investing from some thousand SEK up to a couple of million SEK. In total, t... |
